A private placement led by T. Rowe Price has pulled in $8.5 million for Quanterix. The proceeds will be used to expand the company's assay menu and develop new instruments, as well as to "meet global demand for the company's proprietary platform across therapeutic markets," the company said.
Private placement brings in $8.5M for Quanterix
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.